Q32 Bio Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 02/17/2026 | 2.25 M | $7.48 M | 0.00% | 18.41% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 02/13/2026 | 2.09 M | $6.95 M | 0.00% | 17.09% |
| CARLYLE GROUP INC. | 02/13/2026 | 1.10 M | $3.62 M | 0.00% | 9.01% |
| ACORN CAPITAL ADVISORS, LLC | 02/17/2026 | 493.43 K | $1.64 M | -38.58% | 4.03% |
| VANGUARD GROUP INC | 01/29/2026 | 321.05 K | $1.07 M | 8.68% | 2.62% |
| ARCH VENTURE MANAGEMENT, LLC | 02/17/2026 | 320.48 K | $1.06 M | 0.00% | 2.62% |
| PFIZER INC | 02/12/2026 | 277.78 K | $922.22 K | 0.00% | 2.27% |
| SANOFI | 02/11/2026 | 244.08 K | $810.36 K | 0.00% | 1.99% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 213.36 K | $708.37 K | 100.00% | 1.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 106.11 K | $352.40 K | 19.91% | 0.87% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 99.60 K | $330.67 K | 110.57% | 0.81% |
| BLACKROCK, INC. | 02/12/2026 | 59.93 K | $198.97 K | -35.56% | 0.49% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 51.27 K | $170.21 K | -51.07% | 0.42% |
| MONACO ASSET MANAGEMENT SAM | 02/10/2026 | 50.92 K | $169.05 K | -83.63% | 0.42% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 48.37 K | $159.00 K | 62.66% | 0.40% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 46.83 K | $155.46 K | 48.62% | 0.38% |
| CITADEL ADVISORS LLC | 02/17/2026 | 45.73 K | $151.82 K | 351.99% | 0.37% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 27.78 K | $92.22 K | 0.00% | 0.23% |
| JANE STREET GROUP, LLC | 02/12/2026 | 25.37 K | $84.24 K | 100.00% | 0.21% |
| NORTHERN TRUST CORP | 02/17/2026 | 25.03 K | $83.11 K | -21.66% | 0.20% |
| HRT FINANCIAL LP | 02/12/2026 | 24.70 K | $81.00 K | 66.47% | 0.20% |
| STATE STREET CORP | 02/13/2026 | 21.24 K | $70.51 K | 0.00% | 0.17% |
| XTX TOPCO LTD | 02/17/2026 | 20.35 K | $67.57 K | 100.00% | 0.17% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 20.00 K | $66.40 K | 100.00% | 0.16% |
| SCIENTECH RESEARCH LLC | 02/17/2026 | 15.51 K | $51.49 K | 100.00% | 0.13% |
| UBS GROUP AG | 01/29/2026 | 13.61 K | $45.17 K | 159.36% | 0.11% |
| MORGAN STANLEY | 02/13/2026 | 5.48 K | $18.19 K | -51.71% | 0.04% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 4.64 K | $15.41 K | -7.66% | 0.04% |
| FMR LLC | 02/17/2026 | 3.36 K | $11.17 K | -78.80% | 0.03% |
| FEDERATED HERMES, INC. | 02/12/2026 | 2.27 K | $7.55 K | -4.25% | 0.02% |
| GLOBAL RETIREMENT PARTNERS, LLC | 02/06/2026 | 1.50 K | $4.98 K | -70.00% | 0.01% |
| SRS CAPITAL ADVISORS, INC. | 02/13/2026 | 1.11 K | $3.69 K | -8.56% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.04 K | $3.44 K | -32.13% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 976 | $3.24 K | -84.94% | 0.01% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 03/17/2026 | 577 | $1.92 K | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 500 | $1.66 K | 100.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 454 | $1.51 K | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 324 | $1.08 K | 8,000.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 308 | $1.02 K | -28.70% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 235 | $1.00 K | -77.68% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/15/2026 | 166 | $551 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 157 | $521 | -98.08% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 132 | $437 | -29.41% | 0.00% |
| ALLWORTH FINANCIAL LP | 02/05/2026 | 98 | $326 | -83.93% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 70 | $231 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 34 | $113 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/10/2026 | 30 | $100 | 100.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 19 | $63 | -97.69% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/09/2026 | 11 | $37 | 0.00% | 0.00% |
| ADVISORNET FINANCIAL, INC | 01/20/2026 | 2 | $7 | 0.00% | 0.00% |
Q32 Bio Inc. institutional Ownership - FAQ's
During the previous two years, 58 institutional investors and hedge funds held shares of Q32 Bio Inc.. The most heavily invested institutionals were:
Cambridge Investment Research Advisors, Inc.: 35,025
UBS Group AG: 270
NISA INVESTMENT ADVISORS, LLC: 166
SBI Securities Co., Ltd.: 104
AdvisorNet Financial, Inc: 2
ORBIMED ADVISORS LLC: 2.25 M
65.71% of Q32 Bio Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.46 M shares in the last 24 months. This purchase volume represents approximately $43.16 M in transactions.